about
Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vectorTowards Therapeutic Delivery of Extracellular Vesicles: Strategies for In Vivo Tracking and Biodistribution AnalysisGeneration of helper-dependent adenoviral vectors by homologous recombination.PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile.Modulation of TNFalpha, a determinant of acute toxicity associated with systemic delivery of first-generation and helper-dependent adenoviral vectors.Enhanced healing of diabetic wounds by topical administration of adipose tissue-derived stromal cells overexpressing stromal-derived factor-1: biodistribution and engraftment analysis by bioluminescent imaging.Effects of the olive-derived polyphenol oleuropein on human healthFacial skin rejuvenation by autologous dermal microfat transfer in photoaged patients: Clinical evaluation and skin surface digital profilometry analysis.Human epicardium-derived cells fuse with high efficiency with skeletal myotubes and differentiate toward the skeletal muscle phenotype: a comparison study with stromal and endothelial cells.A role for neuronal cAMP responsive-element binding (CREB)-1 in brain responses to calorie restrictionMolecular imaging of nuclear factor-Y transcriptional activity maps proliferation sites in live animals.Promotion of Survival and Engraftment of Transplanted Adipose Tissue-Derived Stromal and Vascular Cells by Overexpression of Manganese Superoxide Dismutase.Apoptosis induced by a HIPK2 full-length-specific siRNA is due to off-target effects rather than prevalence of HIPK2-Δe8 isoform.Monitoring the Response of Hyperbilirubinemia in the Mouse Brain by In Vivo Bioluminescence Imaging.Spontaneous myogenic differentiation of Flk-1-positive cells from adult pancreas and other nonmuscle tissues.Identification of protein disulfide isomerase as a cardiomyocyte survival factor in ischemic cardiomyopathy.p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditionsChallenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies.Adenovirus vectors targeting alphaV integrin or heparan sulfate receptors display different distribution of transgene activity after intramuscular injection.Reduced inflammation and improved airway expression using helper-dependent adenoviral vectors with a K18 promoter.Sirtuins 1-7 expression in human adipose-derived stem cells from subcutaneous and visceral fat depots: influence of obesity and hypoxia.A CREB-Sirt1-Hes1 Circuitry Mediates Neural Stem Cell Response to Glucose Availability.Human cord blood CD34+ progenitor cells acquire functional cardiac properties through a cell fusion process.Harvest of superficial layers of fat with a microcannula and isolation of adipose tissue-derived stromal and vascular cells.Role of HIF-1alpha in proton-mediated CXCR4 down-regulation in endothelial cells.Stem cells under the influence of alcohol: effects of ethanol consumption on stem/progenitor cellsProtein disulfide isomerase as a prosurvival factor in cell therapy for muscular and vascular diseasesOverexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer developmentFluid Cartilage as New Autologous Biomaterial in the Treatment of Minor Nose Defects: Clinical and Microscopic Difference Amongst Diced, Crushed, and Fluid CartilageEffects of Copper Chelation on BRAFV600E Positive Colon Carcinoma Cells.Current Biomedical Use of Copper Chelation TherapyIn vivo Bioluminescence-Based Monitoring of Liver Metastases from Colorectal Cancer: An Experimental ModelIntraoperative Strategies for Minimal Manipulation of Autologous Adipose Tissue for Cell- and Tissue-Based Therapies: Concise ReviewExtracellular Vesicles-Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell ProliferationDHA Affects Microtubule Dynamics Through Reduction of Phospho-TCTP Levels and Enhances the Antiproliferative Effect of T-DM1 in Trastuzumab-Resistant HER2-Positive Breast Cancer Cell Lines
P50
Q24555782-A7E6B77C-62E4-4B1D-A171-FD0DFAC5EBCCQ28075450-C886DD2B-51C2-48EB-9002-B78FC132944FQ33340918-B259B796-3094-4B9C-A980-E168518CE5D8Q33364520-7FBC2E3A-FD07-4750-B831-55298FABAA79Q33371239-FF8CF338-2A7E-474D-AEDE-A93E46919A05Q34158926-A61E4376-20BF-4E6A-A769-45713D18434BQ34486880-65AE077D-C009-49D6-9D73-4AC4A61DAECFQ34556984-F83CBF18-C3EA-44EE-98CA-FA414AAA821EQ34611643-4B03E0AF-4810-4F2A-ADC3-934EED82EBBEQ35673630-D2B7EEA8-8CA2-4BD4-9F85-99893CFA29B7Q35891239-64717DA2-4052-41D0-B679-D092D69B13C9Q36072645-63996958-674E-440B-B975-9FF3962E8F4CQ36738933-7BE2C667-6A4C-4908-AE7A-66F7393E3191Q37631453-7EAC3772-8A18-4EF8-8575-304A342A2E3CQ40033034-1BD1216D-0703-466D-A9F4-D37A75454A66Q40176298-2D9CD6CF-9214-41A8-88E4-D46315CF4F03Q41279239-64B14AA8-E188-4278-A52F-CE279FC8AA2AQ44298061-567A4A7B-59B2-4C44-A688-2F1B3AF56130Q44803106-0763048A-0C74-4392-AE1F-104E0EA38CC6Q45861955-A0AAADB8-456F-4E99-A721-C223DDEC02ABQ48227246-D840A040-13D3-45FA-A627-A4B88C757433Q48952399-CF608F27-73F5-40DB-95BF-19C11F18AAD9Q50525938-A92716C0-4B2F-467C-890C-67827B80AD6EQ50620101-D0103AAB-2D88-4A10-A74D-16ED2D75AEFEQ51561772-6818A7E3-A844-4A14-B3D2-97BE00463C0EQ57283118-F1E89D2B-B86F-489E-BCB5-DF4E548D9A42Q58694834-CC871C72-5148-48D1-B44B-C3E3D264FF67Q64079819-B8A7CCCA-857D-4630-815E-D60E88C3510FQ64099132-D5172B03-E66E-42BD-B595-6D8ABD2746A9Q64949252-C5630C1A-A9BE-4E23-9FB3-A3390BD6AB9EQ89633274-A7E6D143-97C0-4DC7-B664-1ACBC79DCC86Q90245125-0FF7DB39-BCB8-4DEB-B3B2-9298EA55F7A7Q90625419-1DFFF2AD-FB1D-4435-A44F-956964CAA8E7Q91807824-461A58E5-540A-4293-9028-885F4586D93CQ95304752-C4009096-1DDB-44ED-ABA9-0A0D172CF26B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gabriele Toietta
@ast
Gabriele Toietta
@en
Gabriele Toietta
@es
Gabriele Toietta
@nl
type
label
Gabriele Toietta
@ast
Gabriele Toietta
@en
Gabriele Toietta
@es
Gabriele Toietta
@nl
prefLabel
Gabriele Toietta
@ast
Gabriele Toietta
@en
Gabriele Toietta
@es
Gabriele Toietta
@nl
P106
P1153
6508305814
P31
P496
0000-0003-4182-2468